Arndt Vogel
@ArndtVogel
Clinician-scientist, focused on liver cancer & precision oncology, Toronto General Hospital/Princess Margaret Cancer Center 🇨🇦/MHH🇩🇪
23-02-2013 08:40:33
1,5K Tweets
5,5K Followers
426 Following
Adjuvant sintilimab in resected high-risk HCC
Nature Medicine
doi.org/10.1038/s41591…
🔎Phs 2 🇨🇳
👉Benefit for HCC w/ MVI, mRFS, 27.7 vs 15.5
🧐What is the role for Bev in adj. setting?
👉More to come soon... field is moving in HCC
ESMO - Eur. Oncology EASLnews ILCA #livertwitter
